Maxime Dougados Selected Research

Cardiovascular Diseases (Cardiovascular Disease)

1/2023	Risk of major adverse cardiovascular events with tofacitinib versus tumour necrosis factor inhibitors in patients with rheumatoid arthritis with or without a history of atherosclerotic cardiovascular disease: a post hoc analysis from ORAL Surveillance.
1/2020	Treat to target in axial spondyloarthritis: From its concept to its implementation.
3/2015	Application of the European Society of Cardiology, Adult Treatment Panel III and American College of Cardiology/American Heart Association guidelines for cardiovascular risk management in a French cohort of rheumatoid arthritis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Maxime Dougados Research Topics

Disease

123	Rheumatoid Arthritis 01/2024 - 11/2002
59	Ankylosing Spondylitis 01/2023 - 09/2002
58	Axial Spondyloarthritis 02/2024 - 02/2011
46	Pain (Aches) 01/2023 - 02/2002
33	Inflammation (Inflammations) 05/2024 - 04/2005
29	Arthritis (Polyarthritis) 03/2023 - 03/2003
25	Back Pain (Backache) 01/2022 - 09/2005
23	Necrosis 01/2023 - 01/2005
23	Osteoarthritis 01/2023 - 01/2003
22	Rheumatic Diseases (Rheumatism) 05/2022 - 12/2003
21	Infections 01/2022 - 07/2006
15	Fatigue 01/2022 - 08/2003
13	Spondylarthropathies 05/2024 - 03/2002
13	Sacroiliitis 02/2024 - 11/2011
13	Non-Radiographic Axial Spondyloarthritis 01/2023 - 06/2013
12	Psoriasis (Pustulosis Palmaris et Plantaris) 01/2023 - 07/2009
12	Psoriatic Arthritis 12/2022 - 11/2003
9	Uveitis 01/2023 - 04/2004
8	Knee Osteoarthritis 05/2014 - 10/2002
7	Chronic Disease (Chronic Diseases) 11/2020 - 08/2005
7	Hip Osteoarthritis (Coxarthrosis) 02/2014 - 02/2002
6	Synovitis 01/2022 - 04/2005
5	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 02/2024 - 07/2012
5	Juvenile Arthritis (Juvenile Idiopathic Arthritis) 01/2023 - 04/2013
4	COVID-19 01/2023 - 06/2021
4	Fibromyalgia (Fibrositis) 12/2022 - 01/2018
4	Osteoporosis 01/2020 - 09/2005
3	Cardiovascular Diseases (Cardiovascular Disease) 01/2023 - 03/2015
3	Giant Cell Arteritis (Horton Disease) 01/2023 - 01/2016
3	Tuberculosis (Tuberculoses) 01/2023 - 03/2010
3	Rheumatic Fever (Acute Articular Rheumatism) 11/2020 - 12/2006
3	Systemic Lupus Erythematosus (Libman-Sacks Disease) 11/2020 - 12/2014
3	Crohn Disease (Crohn's Disease) 11/2020 - 12/2015
3	Herpes Zoster 10/2020 - 07/2003
3	Neoplasms (Cancer) 01/2020 - 06/2010
3	Hypertension (High Blood Pressure) 01/2018 - 12/2011
3	Body Weight (Weight, Body) 12/2015 - 11/2003
2	Cytokine Release Syndrome 01/2023 - 01/2022
2	Adult-Onset Still's Disease 01/2023 - 01/2022
2	Neuromyelitis Optica (Devic's Disease) 01/2023 - 01/2022

Drug/Important Bio-Agent (IBA)

46	Antirheumatic Agents (DMARD)IBA 03/2023 - 06/2004
38	Etanercept (Enbrel)FDA Link 02/2024 - 07/2003
35	C-Reactive ProteinIBA 01/2023 - 11/2003
29	Methotrexate (Mexate)FDA LinkGeneric 01/2021 - 07/2003
29	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2020 - 07/2003
28	Non-Steroidal Anti-Inflammatory Agents (NSAIDs)IBA 02/2024 - 01/2005
23	Rituximab (Mabthera)FDA Link 06/2021 - 09/2006
20	Tumor Necrosis Factor InhibitorsIBA 01/2023 - 12/2006
18	HLA-B27 Antigen (HLA B27 Antigen)IBA 02/2024 - 09/2002
18	tocilizumab (atlizumab)FDA Link 11/2023 - 01/2013
16	Abatacept (Orencia)FDA Link 11/2023 - 08/2005
16	O,O-diisopropyl-S-benzylthiophosphate (IBP)IBA 01/2020 - 11/2011
14	GlucocorticoidsIBA 01/2021 - 01/2006
13	Adalimumab (Humira)FDA Link 01/2022 - 07/2006
13	Infliximab (Remicade)FDA Link 01/2020 - 03/2002
13	ametantrone (HAQ)IBA 11/2018 - 11/2003
11	Biomarkers (Surrogate Marker)IBA 01/2020 - 03/2005
10	Certolizumab Pegol FDA Link 09/2020 - 12/2012
9	baricitinibIBA 01/2024 - 01/2017
9	AntibodiesIBA 01/2016 - 01/2006
8	secukinumabIBA 02/2024 - 12/2015
8	Anti-Citrullinated Protein AntibodiesIBA 07/2023 - 09/2010
8	Biosimilar PharmaceuticalsIBA 01/2023 - 03/2014
8	Leflunomide (Arava)FDA LinkGeneric 01/2020 - 06/2003
7	tofacitinibIBA 01/2023 - 06/2017
7	Adrenal Cortex Hormones (Corticosteroids)IBA 01/2019 - 01/2006
6	Interleukin-17 (Interleukin 17)IBA 01/2023 - 01/2015
6	Janus Kinase InhibitorsIBA 01/2022 - 06/2017
6	golimumab FDA Link 01/2022 - 03/2014
5	Interleukin-6 (Interleukin 6)IBA 01/2023 - 04/2013
5	ixekizumabIBA 01/2022 - 12/2018
5	SteroidsIBA 01/2020 - 03/2007
5	AntigensIBA 01/2020 - 11/2003
5	Vitamin D FDA LinkGeneric 01/2020 - 05/2016
5	Monoclonal AntibodiesIBA 01/2019 - 07/2006
5	Prostaglandins AIBA 06/2018 - 11/2006
5	Rheumatoid FactorIBA 01/2016 - 07/2006
4	Guanosine Diphosphate (GDP)IBA 01/2022 - 04/2016
4	Sulfasalazine (Azulfidine)FDA LinkGeneric 01/2020 - 06/2004
4	Proteins (Proteins, Gene)FDA Link 01/2016 - 11/2003
3	InterleukinsIBA 01/2023 - 01/2020
3	bimekizumabIBA 01/2023 - 01/2020
3	Janus KinasesIBA 10/2020 - 06/2017
3	VaccinesIBA 01/2020 - 01/2019
3	CytokinesIBA 01/2020 - 07/2015
3	Prednisone (Sone)FDA LinkGeneric 01/2020 - 12/2018
3	EnzymesIBA 12/2016 - 06/2004
3	Immunoglobulin G (IgG)IBA 01/2016 - 07/2006
3	Immunoglobulin M (IgM)IBA 01/2016 - 12/2007
3	Peptides (Polypeptides)IBA 12/2014 - 03/2013
3	cyclic citrullinated peptideIBA 10/2013 - 01/2006
3	amsonic acid (DAS)IBA 03/2012 - 12/2003
2	Chimeric Antigen ReceptorsIBA 01/2023 - 01/2022
2	4-hexyloxyaniline (HOA)IBA 01/2023 - 07/2021

Therapy/Procedure

74	Therapeutics 05/2022 - 11/2002
6	Biological Therapy 02/2024 - 10/2013
6	Replacement Arthroplasty 01/2016 - 11/2003
5	Injections 11/2023 - 04/2005
5	Hip Replacement Arthroplasty (Total Hip Replacement) 07/2009 - 02/2002
3	Aftercare (After-Treatment) 01/2019 - 10/2010